期刊
CLINICAL BIOCHEMISTRY
卷 36, 期 8, 页码 641-645出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0009-9120(03)00110-3
关键词
molecular diagnosis; monogenic disease; lipoproteins; renal disease; neuropathy
Objectives: Amyloidosis results from local or systemic extracellular deposition of insoluble protein fibrils and is associated with certain rare mutations in APOA1 encoding apolipoprotein (apo) A-I. Design and methods: In a patient with renal-predominant amyloidosis with neuropathy, we found the APOA1 G26R mutation. Conclusions: While the spectrum of APOA1 mutations provides no particular mechanistic insights, molecular diagnosis may still be important due to clinical differences between amyloidosis resulting from mutation in APOA1 vs. other genes. (C) 2003 The Canadian Society of Clinical Chemists. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据